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Abstract
Background: The NF-κB signaling pathway plays a role in local and remote tissue damage following ischemia-reperfusion
(I/R) injury to skeletal muscles. Evidence suggests that exosomes can act as intercellular communicators by
transporting active proteins to remote cells and may play a role in regulating inflammatory processes. This
study aimed to profile the exosomal protein expression in the serum of NF-κB knockout mice following skeletal
muscle ischemia-reperfusion injury.
Results: To investigate the potential changes in protein expression mediated by NF-κB in secreted exosomes
in the serum following I/R injury, the levels of circulating exosomal proteomes in C57BL/6 and NF-κB−/− mice
were compared using two dimensional differential in-gel electrophoresis (2-DE), liquid chromatography tandem
mass spectrometry (LC-MS/MS), and proteomic analysis. In C57BL/6 mice, the levels of circulating exosomal proteins,
including complement component C3 prepropeptide, PK-120 precursor, alpha-amylase one precursor, beta-enolase
isoform 1, and adenylosuccinate synthetase isozyme 1, increased following I/R injury. However, in the NF-κB−/− mice,
the expression of the following was upregulated in the exosomes: protease, serine 1; glyceraldehyde-3-phosphate
dehydrogenase-like isoform 1; glyceraldehyde-3-phosphate dehydrogenase; and pregnancy zone protein. In contrast,
the expression of apolipoprotein B, complement component C3 prepropeptide, and immunoglobulin kappa light chain
variable region was downregulated in NF-κB−/− mice. Bioinformatic annotation using the Protein Analysis
Through Evolutionary Relationships (PANTHER) database revealed that the expression of the exosomal proteins
that participate in metabolic processes and in biological regulation was lower in NF-κB−/− mice than in C57BL/6 mice,
whereas the expression of proteins that participate in the response to stimuli, in cellular processes, and in the immune
system was higher.
Conclusions: The data presented in this study suggest that NF-κB might regulate exosomal protein expression
at a remote site via circulation following I/R injury.
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Background
Ischemia-reperfusion (I/R) injury to the skeletal
muscle leads to the production of oxygen free radicals,
resulting in the occurrence of tissue lipid peroxidation
upon re-oxygenation, and release of pro-inflammatory
cytokines such as IL-6, IL-1, and TNF-α through the
NF-κB signaling pathway. In addition, I/R injury to
the skeletal muscle not only affects the muscle but
also causes injury to remote organs, which can lead
to multiple organ failure and death [1–3]. NF-κB
plays an important role in the pathogenesis of I/R
injury to the skeletal muscle. Regulation of the initial
phase of NF-κB activation provides physiological
protection against severe ischemic stress [4, 5]. Se-
lective inhibition of NF-κB has been suggested as a
potential therapeutic intervention to treat I/R injury
[6, 7]. Moreover, it has been reported that inhibition
of NF-κB prevents local and remote organ injury fol-
lowing I/R injury [8].
Exosomes are small, spherical vesicles that are se-
creted upon fusion of the limiting membrane of multi-
vesicular bodies with the plasma membrane [9]. It has
been proposed that exosomes act as intercellular com-
municators with the carried active cytosolic proteins,
mRNAs, and miRNAs [10]. The exosome content can
also be transferred into the target cells, either through
the direct fusion of exosomes with the cell membrane
or through active uptake, which is mediated by endo-
cytosis [11, 12]. The secretion of functional proteins
by several cell types, including those of the skeletal
muscle [13, 14], has been described as being associ-
ated with exosomes [15–17], and is involved in cellular
stress responses [18–20] as well as in the modulation
of immunological responses [19, 21, 22]. Importantly,
the presence of oxidative or hypoxic stress can modulate
the expression of biologically active proteins in cell-
derived exosomes [9, 20, 22–24], suggesting that stress-
related signaling via the exosomes could occur through
the transfer of the exosomal protein content.
However, the active circulating exosomal proteins
that may potentially participate in the regulation of
biological responses following I/R injury to the skeletal
muscle remain poorly understood. Moreover, although
the inhibition of the NF-κB signaling pathway prevents
injury to remote organs following I/R injury [8], it
is not known whether there is an NF-κB-mediated
change in the expression of circulating exosomal pro-
teins during I/R injury. Therefore, the aim of this
study was to profile the change in the expression of
exosomal proteins in the serum of C57BL/6 and NF-κB−/−
mice following I/R injury to the skeletal muscle, using the
complementary techniques of two-dimensional electro-




Twelve NF-κB−/− (B6.Cg-Nfkb1tm1Bal/J) mice purchased
from the Jackson Laboratory (Bar Harbor, ME, USA) and
twelve C57BL/6 mice purchased from BioLasco were used
in this study (Taipei, Taiwan). The animals were housed in
a specific-pathogen-free (SPF) facility that is accredited by
the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC). All
surgical procedures, including analgesia, were performed
according to national and institutional guidelines. Animal
protocols were approved by the Institutional Animal Care
and Usage Committee of the Chang Gung Memorial Hos-
pital (permission number No. 2012091304). Briefly, mice
were anesthetized using intraperitoneal injection of an
anesthetic cocktail, which consisted of 0.1 mg/g ketamine
and 0.01 mg/g xylazine (0.01 mL/g body weight). The
anesthetized mice were restrained in the supine position
on a heated pad to maintain their body temperature at
37 °C. The model of skeletal muscle I/R injury was per-
formed according to our previous report [25]. The quadri-
ceps muscle was perfused at the femoral artery and was
then carefully separated from the femoral bone and from
the underlying adductor muscle group. In the ischemic ex-
perimental group, ischemia was induced by carefully pla-
cing a microvascular clamp across the proximal site of the
vascular pedicle for 4 h, after which the clamp was re-
moved. The presence of good vascular flow through the
pedicle was verified with direct magnified vision. In the
sham-operated group, the muscle was isolated without in-
ducing ischemia with a microvascular clamp. The incision
wound was closed with interrupted sutures (4–0 nylon su-
tures), and the animals were allowed to awaken during the
remaining reperfusion time.
Muscle histochemistry
To evaluate basic muscle morphology after I/R injury, the
muscles of sham-operated mice and of experimental mice
subjected to ischemia for 4 h and reperfusion for 4 h, 1 day,
or 7 days were harvested. The muscles were subsequently
covered in Tissue Tek O.C.T. compound (Sakura Finetek
Inc., Torrance, CA, USA), frozen in liquid nitrogen–cooled
isopentane, and stored at −80 °C until cryosectioning
(7 μm). Sections were stained with hematoxylin and eosin.
Western blotting of nuclear p65
Nuclear protein extracts of the experimental muscles of
C57BL/6 and NF-κB−/− mice at 4, 16, and 48 h after I/R
injury were used for Western blot analysis using NE-PER
extraction reagents according to the manufacturer’s
protocol (Pierce Biotechnology, Rockford, IL). Protein
extracts (30 μg) were separated on 10 % SDS-
polyacrylamide gels, and transferred to nitrocellulose
membranes. Membranes were blocked using nonfat
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milk in Tween-20/Tris-buffered saline (TBST), and in-
cubated with monoclonal rabbit anti-p65 antibody (Cell
Signalling) and anti-lamin B1 (Santa Cruz, CA, USA),
followed by goat anti-rabbit horseradish peroxidase-
conjugated secondary antibodies. Nuclear extract of
human umbilical vein endothelial cells (HUVECs)
against 10 ug/mL LPS (L3755; Sigma, St Louis, MO)
treatment for 24 h was used for positive control of p65
expression according to our previous report [26]. The
expression of nuclear p65 protein was assessed against
that of lamin B1 using a FluorChem 8900 imaging sys-
tem (Alpha Innotech, San Leandro, CA) (n = 4), and
the intensity of each band was quantified using auto-
background subtraction during spot density analysis
using the AlphaEaseFC software (Alpha Innotech).
Exosome isolation
For proteomic analysis of the exosome contents, six
C57BL/6 mice and six NF-κB−/− mice were used; in both
cases, three mice were from the sham-operated group
and three from the I/R injury experimental group.
Whole blood was drawn from the sham-operated mice
and mice subjected to ischemia for 4 h and reperfusion
for 1 day, respectively, and collected in RNAprotect Ani-
mal Blood Tubes (Qiagen, Valencia, CA, USA) without
anticoagulant. The whole blood samples were incubated
at room temperature for 15 min and centrifuged at
3000 × g for 15 min. Subsequently, white blood cells
were carefully removed from the corresponding layers,
and the serum (250 μL) was extracted and thawed on
ice. The supernatants were transferred to sterile tubes
containing 63 μL ExoQuick Precipitation Solution (Sys-
tem Biosciences, Mountain View, CA, USA) and were
then mixed. The mixtures were incubated for a mini-
mum of 12 h at 4 °C and were subsequently centrifuged
at 1500 × g for 30 min at 4 °C. The resuspended exo-
some pellets were then lysed in a protein lysis buffer.
Scanning electron microscopy
The exosome isolates were attached to double-sided ad-
hesive tape, fixed to a stage, and then coated with nano-
gold particles. The exosomes were photographed using a
JEOL JSM-5300 scanning electron microscope (Tokyo,
Japan) for analysis of size and morphology.
Proteomic analysis
The exosomes were lysed in lysis buffer containing 2 % so-
dium dodecyl sulfate (SDS), 1 % Triton-X100, 0.1 M Tris
(pH 7.4), and one tablet of Complete EDTA-free protease
inhibitors (Roche, Indianapolis, IN, USA). Protein concen-
trations in the exosome lysates were determined using a
BCA protein assay (Pierce, Rockford, IL, USA). The lysis
mixture was incubated at room temperature for 60 min
and was then centrifuged at 15,000 × g for 60 min at 4 °C.
Following centrifugation, the resulting supernatant was
collected and then quantified with a 2D QUANT Protein
Assay Kit (GE Healthcare, Piscataway, NJ, USA). The
supernatant containing 300 μg of total cellular protein
(20 μL) was mixed with a sample buffer (7 M urea, 2 M
thiourea, 4 % CHAPS, 65 mM DTT, 0.2 % ampholytes,
and a small amount of bromophenol blue) to obtain a final
volume of 450 μL. 2-DE analysis was performed using a
24 cm Immobiline DryStrip (GE Healthcare). Subsequent
rehydration followed by isoelectric focusing (set at the
highest current, 50 μA/gel, 20 °C) and then SDS-
polyacrylamide gel electrophoresis were performed. Fol-
lowing electrophoresis, silver staining, which is compatible
with mass spectrometry, was conducted. The gel was
scanned using a UMAX Power Look 1100 transmission
scanner to obtain images, which were subsequently ana-
lyzed with the PDQuest software, version 7.1.0. The pro-
tein spots (protein expression with changes greater than
twofold, following I/R injury) were excised from the gels
and were then subjected to in-gel digestion, after which
LC-MS/MS was performed. The resulting data were ana-
lyzed using the Mascot database.
Enzyme-linked immunosorbent assay (ELISA)
To investigate whether the exosomal proteins identified
are also present in the serum or the experimental skel-
etal muscle after I/R injury, expression of a representa-
tive exosomal protein, the complement component C3
prepropeptide, which was upregulated in C57BL/6 mice
but downregulated in the exosomes of NF-κB−/− mice,
was measured. The analysis was performed using exo-
somes from the sham-operated mice and from mice sub-
jected to 4-h ischemia and reperfusion for 1 d (n = 4 for
each group). C3 prepropeptide expression was measured
by ELISA using a commercially supplied kit (Genway
Biotech, San Diego, CA, USA). Briefly, each sample was
diluted 1/100,000 in blocking buffer (50 mM Tris,
0.14 M NaCl, 1 % BSA, pH 8.0) and added to the wells
of a 96-well plate coated with 100 μl of 2 μg/ml rabbit
anti-human C3 prepropeptide. After incubation with
1:10,000 diluted horseradish peroxidase conjugate,
100 μl enzyme substrate 3,3',5,5'-tetramethylbenzidine
(TMB) was added for 30 min, then 100 μl of 2 M H2SO4
was applied to each well to stop the TMB reaction. The
absorbance at 450 nm was measured using an ELISA
plate reader. Each dilution was measured alongside a set
of standards and the results averaged. Results are
expressed as micrograms per milliliter (μg/mL) of serum
and exosomes or per milligram (μg/mg) of tissue protein.
Functional analysis of the exosomal proteome
Proteins that had twofold or greater expression and were
identified by LC-MS/MS were analyzed using the Protein
Analysis Through Evolutionary Relationships (PANTHER;
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http://www.pantherdb.org) classification system. The PAN-
THER classification system is a comprehensive method that
combines gene function, gene ontology (GO), pathway, and
statistical analysis tools to facilitate the analysis of large-
scale, genome-wide data from sequencing, proteomics,
or gene expression experiments [27]. The PANTHER
system allows the prediction of protein classifications
based on the proteins’ GO, biological processes, and
molecular functions.
Results
Histological analysis involving hematoxylin and eosin
staining of the muscles from the experimental group con-
firmed the presence of I/R injury (Fig. 1). In comparison
to the findings in the sham-operated group, increased
swelling of muscle fibers with loss of contact integrity
among muscle fibers and increased cellular infiltration
were found after I/R injury. This morphological change in
muscle fibers could still be observed 7 days after the I/R
injury. Western blot analysis of the nuclear protein ex-
tracts revealed a significant p65 nuclear translocation in
the experimental muscle at 4 and 16 h but not 48 h after
I/R injury in the C57BL/6 mice. In contrast, no p65 nu-
clear translocation was found in the NF-κB−/−mice (Fig. 2).
The electron microscopy experiments performed using
the purified exosome samples obtained from the serum
revealed the presence of vesicles that were derived from
a C57BL/6 mouse, with an approximate diameter of
50–200 nm (Fig. 3). A proteomics approach involving
2-DE was used to characterize the changes occurring in
the serum exosomes following I/R injury and to com-
pare such changes seen in C57BL/6 and NF-κB−/− mice.
The resulting protein pattern was observed in a silver-
stained 2-DE gel, and a representative image is shown
in Fig. 4. The imaging software facilitated the analysis
of protein spots on the gel. Protein spots that exhibited
a twofold or greater change in expression levels were
excised from the silver-stained gels and identified using
LC-MS/MS analysis (Table 1). Following I/R injury to
the skeletal muscle in C57BL/6 mice, an increase was
found in the level of circulating exosomal proteins, in-
cluding complement component C3 prepropeptide, PK-
120 precursor, alpha-amylase 1 precursor, beta-enolase
isoform 1, and adenylosuccinate synthetase isozyme 1.
However, in the NF-κB−/− mice, the expression of the
following were upregulated in the exosomes: protease,
serine 1; glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)-like isoform 1; GAPDH; and pregnancy zone
protein. The expression of apolipoprotein B (ApoB),
complement component C3 prepropeptide, and im-
munoglobulin kappa light chain variable region was
downregulated in NF-κB−/− mice. In C57BL/6 mice, the
expression levels of C3 prepropeptide in the exosomes
and serum after I/R injury were significantly higher
than those in the sham group (Fig. 5). However, the
fold increase in expression was much higher in the exo-
somes than in the serum, indicating that the majority
of the C3 prepropeptide was located in exosomes. In
contrast, the expression level of C3 prepropeptide was
significantly lower in both exosomes and serum of the
NF-κB−/− mice after I/R injury. There was no signifi-
cant change in C3 prepropeptide expression in the I/R
skeletal muscle in both C57BL/6 and NF-κB−/− mice,
indicating that the I/R muscle is not the source of C3
prepropeptide in the exosomes. The data were subse-
quently subjected to ontology and pathway analyses
using the PANTHER software and were then classified
based on their respective protein classes, molecular
functions, and biological processes. Exosomal proteins
that were found to have a greater than twofold change
Fig. 1 Hematoxylin and eosin staining of the cryosectioned muscles of sham-operated mice and the muscles of experimental mice subjected to
ischemia for 4 h and reperfusion for 4 h, 1 day, or 7 days
Yang et al. Journal of Biomedical Science  (2015) 22:40 Page 4 of 9
in expression following I/R injury in the NF-κB−/− mice
were classified into six GO categories, that is, immunity
proteins (22.2 %), enzyme modulators (22.2 %), hydro-
lases (11.1 %), oxidoreductases (11.1 %), proteases
(11.1 %), and signaling molecules (11.1 %). However, in
the C57BL/6 group, the functions of the differentially
expressed genes consisted of enzyme modulators
(28.6 %), hydrolases (14.3 %), ligases (14.3 %), lyases
(14.3 %), signaling molecules (14.3 %), and immunity
proteins (14.3 %) (Fig. 6). In terms of the molecular
function categories, the proteins in both mouse groups
that belonged to the functional categories of regulation
of enzyme activity, binding, and catalytic activity were
highly overrepresented (Fig. 6). In terms of the bio-
logical processes, most of the clusters identified were
associated with the categories of metabolic processes,
responses to stimuli, biological regulation, cellular pro-
cesses, and immune system processes (Fig. 7). The ex-
pression of proteins that participate in metabolic
processes and biological regulation was lower in NF-κB
−/− mice than in C57BL/6 mice, whereas the expression
of proteins that participate in the response to stimuli,
cellular processes, and immune system processes was
higher.
Discussion
Our analysis revealed that, during I/R injury, the NF-κB-
mediated alterations in the expression of circulating exo-
somal proteins are related to biological processes that
are involved in complement activation, proteolysis, cellu-
lar processes, response to stimuli, regulation of catalytic
activities, and glycolysis. The putative influences of these
proteins on the downstream pathways that are related to
I/R include cellular processes, cell communication, and
signaling pathways. Based on the classes of exosomal
proteins, our data also revealed that the expression of
oxidoreductases is upregulated in NF-κB groups, sug-
gesting that the inhibition of NF-κB may modify the ex-
pression of the redox modulation enzymes in the
exosomes secreted. Oxidoreductases are enzymes that
catalyze numerous redox reactions. Their actions include
the catalysis of the transformation of free, neutral oxy-
gen gas into oxygen free radicals, superoxide, hydroper-
oxide, single oxygen molecules, and hydrogen peroxide.
They also make up the most important free radical
Fig. 2 Expression fold of p65 in Western blot analysis of the nuclear protein extracts of the experimental muscles at 4, 16, and 48 h after I/R injury in C57BL/6
and NF-κB−/− mice. (*p< 0.01, compared to sham-operated mice in quadruplicate) Ctrl, Control sham-operated mice; Pos, Positive control of p65 expression
Fig. 3 Electron microscopic image of purified serum exosomes
derived from a normal C57BL/6 mouse
Fig. 4 2-DE protein patterns in serum exosomes from C57BL/6 and
NF-κB−/− mice after I/R injury. (a) C57BL/6 sham control; (b) C57BL/6
I/R injury; (c) NF-κB-/- sham control; (d) NF-κB-/- I/R injury.
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scavenger systems exemplified by catalase, superoxide
dismutase, and glutathione peroxidase [28]. Oxidoreduc-
tases represent one of the most important free radical
scavenger systems and play a cytoprotective role beyond
their antioxidant function [29–31]. The possibility of
exosomal oxidoreductases in the NF-κB−/− mouse serum
contributing to a protective role for the distal organs
after I/R muscle injury is interesting and requires further
investigation.
The complement system is a host defense system that
identifies injured cells, recruits inflammatory cells, and in-
duces cell lysis [32]. The complement component C3 is a
pro-inflammatory protein and an important component of
the complement cascade. Expression of complement com-
ponent one is elevated through oxidative stress following is-
chemic reperfusion [33]. Moreover, many reports have
attributed the protective effects of antioxidants to their cap-
acity to suppress the expression of complement component
C3 [34–36] and the subsequent blocking of NF-κB activa-
tion which inhibits complement component 3 [37]. Import-
antly, the complement cascade has been implicated in the
process of I/R injury. In this study, the expression of the
complement component C3 prepropeptide in the serum
exosomes of C57BL/6 mice was upregulated in response to
I/R muscle injury; however, the expression of this protein
was downregulated in NF-κB−/− mice. In addition, although
the expression levels of C3 prepropeptide were significantly
higher in the exosomes and serum after I/R injury, the fold
increase in expression was much higher in the exosomes
than in the serum, indicating that most of the C3 prepro-
peptide was located in the exosomes. Thus, exosomes may
participate in inflammatory processes in remote organs
during I/R muscle injury; however, such inflammatory ef-
fects transmitted by exosomes may decrease during NF-κB
inhibition. However, this hypothesis requires further experi-
ments to be validated.
The upregulation of protease, serine one and preg-
nancy zone protein, an inhibitor of proteinases, was ob-
served in the NF-κB−/− groups, suggesting that the
modulation of the function of T lymphocytes and fi-
brinolysis by these proteins was negatively regulated
through the NF-κB pathway following I/R injury [38,
39]. GAPDH, a glycolytic enzyme, has been recently
identified as being involved in the initiation of apop-
tosis [40]. The expression of a phosphorylation-
defective GAPDH mutant during I/R injury reduces cell
apoptosis [41], suggesting that GAPDH may play a crit-
ical role in the progression and spread of ischemic
damage [42]. In this study, the expression of exosomal
GAPDH was upregulated in the NF-κB−/− groups, sug-
gesting that the expression of exosomal GAPDH is NF-
κB-independent and that there may be a negative
Table 1 Proteins exhibiting a twofold or greater change in expression levels in serum exosomes from C57BL/6 and NF-κB−/− mice in
response to I/R injury (p < 0.05)
ID Name Score Expression
C57BL/6 gi|387114 complement component C3 prepropeptide 1963 up
gi|2739028 PK-120 precursor 2421 up
gi|160358819 alpha-amylase 1 precursor 2557 up
gi|6679651 beta-enolase isoform 1 850 up
gi|6671519 adenylosuccinate synthetase isozyme 1 1577 up
NF-κB−/− gi|16716569 protease, serine, 1 1330 up
gi|309266468 glyceraldehyde-3-phosphate dehydrogenase-like isoform 1 1346 up
gi|6679937 glyceraldehyde-3-phosphate dehydrogenase 1075 up
gi|34785996 pregnancy zone protein 1192 up
gi|27371137 apolipoprotein B 2617 down
gi|387114 complement component C3 prepropeptide 2372 down
gi|158346648 immunoglobulin kappa light chain variable region 3238 down
Fig. 5 Expression levels of C3 prepropeptide measured by
enzyme-linked immunosorbent assay (ELISA) in the exosomes,
serum, and experimental skeletal muscle of C57BL/6 and NF-κB−/−
mice after I/R injury (*p < 0.01, compared to sham-operated mice
in quadruplicate)
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feedback loop of regulation following I/R injury
through NF-κB-independent pathways.
In our study, the expression of ApoB was downregulated
in NF-κB−/− mice but not in C57BL/6 mice. ApoB is the
primary apolipoprotein of low-density lipoproteins and is
responsible for transporting cholesterol to the tissues. The
retention and modification of ApoB in the extracellular
matrix, followed by proliferation and inflammation, can
lead to the chronic progression of atherosclerotic lesions
[43]. Alpha-amylase is an enzyme that hydrolyses the
bonds of large, α-linked polysaccharides, such as those in
starch and glycogen, yielding glucose and maltose. Our re-
sults indicated that the expression of alpha-amylase pre-
cursor was elevated in C57BL/6 mice. In previous studies,
Fig. 6 Alteration in serum exosome protein expression after I/R injury. Protein classes were identified and analyzed by mass spectrometry
and PANTHER software
Fig. 7 Analysis of exosomal proteins identified by mass spectrometry using PANTHER software. Exosomal proteins isolated from C57BL/6 or NF-κB−/− mice
were classified using PANTHER based on (a) their molecular functions and (b) biological processes
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this enzyme has been described as a biomarker of injury
to peripheral organs in the serum [44, 45]. Ischemia
caused a moderate release of enzymes and an increase in
the activity of alpha-amylase [46]. The damage due to is-
chemia and reperfusion in the pancreas of rats was associ-
ated with increased levels of serum alpha-amylase [47].
The elevated plasma levels of alpha-amylase were also in-
vestigated in advanced chronic heart failure secondary to
ischemic cardiomyopathy [48]. In response to I/R injury,
exosomes may serve as carriers of alpha-amylase in the
serum and elevation of levels of alpha-amylase in circula-
tion is inhibited by the NF-κB signaling pathway.
Although our data do not provide definitive and exact
evidence of the function of the serum exosomes in re-
mote organs following I/R injury, our findings do sup-
plement the current knowledge base regarding their
potential function in the regulation of inflammation.
The data presented in this study suggest that NF-κB
might regulate exosomal protein expression at remote
sites via the circulation, following I/R injury.
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